1. Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990. 33:37–48.
2. Tsao CH, Chen CY, Ou LS, Huang JL. Risk factors of mortality for salmonella infection in systemic lupus erythematosus. J Rheumatol. 2002. 29:1214–1218.
3. Cho YJ, Suh CH, Kim JS, et al. A case of septic arthritis caused by salmonella group D in a patient with systemic lupus erythematosus. J Korean Rheum Assoc. 1999. 6:69–74.
4. Park JK, Ye DK, Yoon WC, et al. A case of rhabdomyolysis and acute renal insufficiency associated with gastroenteritis caused by salmonella group C. Korean J Nephrol. 2000. 19:353–357.
5. Lee MA. Usefulness of selenite F enrichment broth for the isolation of salmonella from stool. Korean J Clin Pathol. 2000. 20:184–187.
6. Saphra I, Winter JW. Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med. 1957. 256:1128–1134.
7. Huang JL, Hung JJ, Wu KC, Lee WI, Chan CK, Ou LS. Septic arthritis in patients with systemic lupus erythematosus: salmonella and nonsalmonella infections compared. Semin Arthritis Rheum. 2006. 36:61–67.
Article
8. Pegues DA, Miller SA. Fauci AS, Braunwald E, Kasper DL, editors. Salmonellosis. Harrison's principles of internal medicine. 2008. 17th ed. New York: McGraw-Hill Medical;956–961.
9. Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore). 1987. 66:349–388.
Article
10. Yu VL, Weber R, Raoult D. Antimicrobial therapy and vaccines. Volume I: Microbes. 2002. 2nd ed. New York: Apple Tree Productions;583–603.